Home / Featured Companies / Gilead Sciences, Historical Data

Gilead Sciences, (GILD) Financials

Gilead Sciences, (GILD) Historical Financial Statements and Key Metrics for 1996 - 2025

Full Gilead Sciences, financials for 1996 - 2025 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Gilead Sciences, Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2025-Mar-31 6,667 5,127 (76.9 %) 2,237 (33.6 %) 1,315 (19.7 %) 2,605 1.04
2024-Dec-31 7,569 5,988 (79.1 %) 2,451 (32.4 %) 1,783 (23.6 %) 3,109 1.42
2024-Sep-30 7,545 5,971 (79.1 %) 888 (11.8 %) 1,253 (16.6 %) 1,884 1.00
2024-Jun-30 6,949 5,405 (77.8 %) 2,688 (38.7 %) 1,614 (23.2 %) 3,382 1.29
2024-Mar-31 6,686 5,134 (76.8 %) 2,302 (34.4 %) -4,170 (-62.4 %) 2,992 -3.34
2023-Dec-31 7,115 5,555 (78.1 %) 2,506 (35.2 %) 1,429 (20.1 %) 3,139 1.14
2023-Sep-30 7,050 5,485 (77.8 %) 2,623 (37.2 %) 2,180 (30.9 %) 2,641 1.73
Full historical income statements for 1996 - 2025 is included in the US Historical Financials dataset.

Gilead Sciences, Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2025-Mar-31 56,434 37,356 24,952 19,162 7,926
2024-Dec-31 58,995 39,749 26,711 19,330 9,991
2024-Sep-30 54,525 36,135 23,249 18,474 5,037
2024-Jun-30 53,579 35,384 23,350 18,281 4,198
2024-Mar-31 56,292 38,837 25,194 17,539 6,059
2023-Dec-31 62,125 39,376 24,987 22,749 8,428
2023-Sep-30 62,373 40,131 25,906 22,242 8,021
Full historical balance sheet data for 1996 - 2025 is included in the US Historical Financials dataset.

Gilead Sciences, Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2025-Mar-31 1,757 -415 -3,426 1,653
2024-Dec-31 2,975 -225 2,260 2,975
2024-Sep-30 4,309 -710 -1,379 4,168
2024-Jun-30 1,325 -307 -2,953 1,195
2024-Mar-31 2,219 -2,207 -1,361 2,114
2023-Dec-31 2,169 -727 -1,099 1,954
2023-Sep-30 1,756 -229 -1,518 1,756
Full historical cash flow data for 1996 - 2025 is included in the US Historical Financials dataset.

Gilead Sciences, Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2025-Mar-31 139,614 156,640 20.94 26.54 7.29
2024-Dec-31 115,278 131,998 15.23 16.16 5.96
2024-Sep-30 104,548 122,760 13.86 20.86 5.66
2024-Jun-30 85,594 106,172 12.32 13.26 4.68
2024-Mar-31 90,881 111,357 13.59 -5.45 5.18
2023-Dec-31 101,100 120,002 14.21 17.69 4.44
2023-Sep-30 93,525 113,726 13.27 10.73 4.20
Full historical valuation and operating metrics for 1996 - 2025 are included in the US Historical Financials dataset.